← Back to companies
Enliven Therapeutics
0 open
Boulder, Colorado, United StatesFounded 201967+ employees$460M raisedIPOELVN
Last round: post ipo equity · $230M · Jun 2025(5 rounds total)
Founded by Anish Patel, Joe Lyssikatos, Sam Kintz
Backed by(14 investors)
Surveyor CapitalCormorant Asset ManagementAcuta Capital PartnersVenrock Healthcare Capital PartnersCommodore CapitalRock Springs CapitalLogos CapitalFairmount Funds ManagementWoodline PartnersBoxer CapitalJanus Henderson InvestorsOrbiMed5AM Ventures
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.
Open Positions at Enliven Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Enliven Therapeutics?
